JACOBS JOSEPH 4

Accession 0001048462-21-000005

CIK 0001196298other

Filed

Jan 28, 7:00 PM ET

Accepted

Jan 29, 4:49 PM ET

Size

23.2 KB

Accession

0001048462-21-000005

Form 4

Period: 2021-01-27

10% Owner

Transactions

Exercise/Conversion
Common Stock
2021-01-27$3.60/sh+3,765$13,554→ 101,560 total
Exercise/Conversion
Stock Option (Right to Buy)
2021-01-27−3,765→ 3,765 total
Exercise: $3.60From: 2018-08-24Exp: 2021-01-29→ Common Stock (3,765 underlying)
Exercise/Conversion
Common Stock
2021-01-27$4.14/sh+2,956$12,238→ 97,795 total
Exercise/Conversion
Common Stock
2021-01-27$4.59/sh+3,556$16,322→ 94,839 total
Exercise/Conversion
Common Stock
2021-01-27$4.50/sh+4,477$20,147→ 106,037 total
Exercise/Conversion
Stock Option (Right to Buy)
2021-01-27−3,556→ 3,556 total
Exercise: $4.59From: 2014-03-24Exp: 2021-01-29→ Common Stock (3,556 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2021-01-27−2,956→ 2,956 total
Exercise: $4.14From: 2016-03-26Exp: 2021-01-29→ Common Stock (2,956 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2021-01-27−4,477→ 4,477 total
Exercise: $4.50From: 2019-12-20Exp: 2021-01-29→ Common Stock (4,477 underlying)

10% Owner

Transactions

Exercise/Conversion
Common Stock
2021-01-27$3.60/sh+3,765$13,554→ 101,560 total
Exercise/Conversion
Stock Option (Right to Buy)
2021-01-27−2,956→ 2,956 total
Exercise: $4.14From: 2016-03-26Exp: 2021-01-29→ Common Stock (2,956 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2021-01-27−4,477→ 4,477 total
Exercise: $4.50From: 2019-12-20Exp: 2021-01-29→ Common Stock (4,477 underlying)
Exercise/Conversion
Common Stock
2021-01-27$4.59/sh+3,556$16,322→ 94,839 total
Exercise/Conversion
Common Stock
2021-01-27$4.14/sh+2,956$12,238→ 97,795 total
Exercise/Conversion
Stock Option (Right to Buy)
2021-01-27−3,556→ 3,556 total
Exercise: $4.59From: 2014-03-24Exp: 2021-01-29→ Common Stock (3,556 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2021-01-27−3,765→ 3,765 total
Exercise: $3.60From: 2018-08-24Exp: 2021-01-29→ Common Stock (3,765 underlying)
Exercise/Conversion
Common Stock
2021-01-27$4.50/sh+4,477$20,147→ 106,037 total

10% Owner

Transactions

Exercise/Conversion
Common Stock
2021-01-27$4.59/sh+3,556$16,322→ 94,839 total
Exercise/Conversion
Common Stock
2021-01-27$4.14/sh+2,956$12,238→ 97,795 total
Exercise/Conversion
Common Stock
2021-01-27$4.50/sh+4,477$20,147→ 106,037 total
Exercise/Conversion
Stock Option (Right to Buy)
2021-01-27−3,556→ 3,556 total
Exercise: $4.59From: 2014-03-24Exp: 2021-01-29→ Common Stock (3,556 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2021-01-27−2,956→ 2,956 total
Exercise: $4.14From: 2016-03-26Exp: 2021-01-29→ Common Stock (2,956 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2021-01-27−3,765→ 3,765 total
Exercise: $3.60From: 2018-08-24Exp: 2021-01-29→ Common Stock (3,765 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2021-01-27−4,477→ 4,477 total
Exercise: $4.50From: 2019-12-20Exp: 2021-01-29→ Common Stock (4,477 underlying)
Exercise/Conversion
Common Stock
2021-01-27$3.60/sh+3,765$13,554→ 101,560 total

10% Owner

Transactions

Exercise/Conversion
Stock Option (Right to Buy)
2021-01-27−4,477→ 4,477 total
Exercise: $4.50From: 2019-12-20Exp: 2021-01-29→ Common Stock (4,477 underlying)
Exercise/Conversion
Common Stock
2021-01-27$3.60/sh+3,765$13,554→ 101,560 total
Exercise/Conversion
Common Stock
2021-01-27$4.50/sh+4,477$20,147→ 106,037 total
Exercise/Conversion
Common Stock
2021-01-27$4.59/sh+3,556$16,322→ 94,839 total
Exercise/Conversion
Common Stock
2021-01-27$4.14/sh+2,956$12,238→ 97,795 total
Exercise/Conversion
Stock Option (Right to Buy)
2021-01-27−3,556→ 3,556 total
Exercise: $4.59From: 2014-03-24Exp: 2021-01-29→ Common Stock (3,556 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2021-01-27−2,956→ 2,956 total
Exercise: $4.14From: 2016-03-26Exp: 2021-01-29→ Common Stock (2,956 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2021-01-27−3,765→ 3,765 total
Exercise: $3.60From: 2018-08-24Exp: 2021-01-29→ Common Stock (3,765 underlying)

Footnotes (5)

[F1]Includes vested and unvested shares of common stock granted to Wexford Capital LP ("Wexford Capital") as reported in Form 4s previously filed by Arthur Amron and Paul Mieyal, respectively, a current and former director of the Company and a current and former employee of Wexford Capital.
[F2]Includes the options reported in the Form 4 filed by Arthur Amron on March 28, 2011.
[F3]Includes the options reported in the Form 4 filed by Arthur Amron on March 27, 2014.
[F4]Includes the options reported in the Form 4 filed by Arthur Amron on August 25, 2016.
[F5]Includes the options reported in the Form 4 filed by Arthur Amron on December 22, 2017.

Documents

1 file

NEPHROS INC

CIK 0001196298

Entity typeother